31.7.2003
No items found.

Market Abuse Directive

Directive 2003/6/EC of the European Parliament and of the Council on Insider Dealing and Market Manipulation (Market Abuse Directive) Official Journal of the European Union of 12 April 2003, L 96, p. 16

The Directive ("Directive") aims at increasing and stabilising investors’ confidence in the European Union securities market, making it more competitive and contributing to its completion and full transparency. The Directive defines both the concept of "insider dealing" and of "market manipulation" and covers a wide scope of financial instruments thus reflecting the increasing number of financial products.

Generally, any financial instrument admitted to trading on a regulated market (within the meaning of Directive 93/22/EC on investment services in the securities field) in at least one Member State, or for which a request for admission to trading on such a market has been made, falls within the scope of its regulation. Prohibitions provided for in the Directive shall not apply to trading in company’s own shares or to the stabilisation of a financial instrument provided, however, that such trading is carried out in accordance with implementing measures to be adopted by the Commission.

Under Article 5 of the Directive, any person is prohibited from engaging in market manipulation. Member States are required to ensure that issuers of financial instruments inform the public as soon as possible of inside information directly relevant to them (including posting such information on the Internet for an appropriate period of time). Issuers may postpone such disclosure for legitimate reasons. However, Member States may require that an issuer inform without delay the competent authority of such decision. The Directive imposes an obligation on managers of an issuer or persons closely associated with them to notify to the competent authority the existence of transactions conducted on their own account relating to shares of the respective issuer. Public access to such information is to be made available.

Each Member State is obliged to designate a single administrative authority to ensure that the provisions adopted pursuant to this Directive are applied. The Directive also encourages further co-operation amongst national supervisory authorities while they are to be supported and extended in terms of competence. Council Directive 89/592/EEC on coordinating regulations on insider dealing is repealed as of 12 April 2003. Member States are obliged to implement the Directive by 12 October 2004.

Separately, acceding Member States may, in duly substantiated cases, as provided under Article 55 of the Act of Accession, apply for temporary derogations from the Directive, as it was adopted between 1st November 2002 and the date of signature of the Treaty of Accession.

Other articles

8.7.2025
News

Advising J&T on the preparation of another bond programme – the Europacity Berlin project.

KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
News

A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein

Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
News

KŠB advised the seller on the sale of mcePharma to the Brenntag Group

The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.